Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
3844-45-9
Name of the chemical
Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl-[(3-sulfophenyl)-methyl]-amino]-phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo, inner salts, disodium salt and its ammonium and aluminium salts (17); (CI 42090)
Concentration
N/A
General Information
Revision date
2020-11-23
Product name
ROBITUSSIN COLD & FLU LIQUID CAPS
Product Synonyms
DEXTROMETHORPHAN HYDROBROMIDE 10 mg, PARACETAMOL 300 mg Capsule, DOXYLAMINE SUCCINATE 6.25 mg, Liquid Filled * WHLNIH
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2
Environmental hazards
Not classified. OSHA defined hazards Not classified.
Signal word
Warning
Hazard statements
Causes skin irritation. Causes serious eye irritation.
Prevention
Wash thoroughly after handling. Wear eye protection/face protection. Wear protective gloves.
Response
If on skin Wash with plenty of water/. If in eyes Rinse cautiously with water for several minutes Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see on this label). If skin irritation occurs Get medical advice/attention. If eye irritation persists Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Not available. Hazard(s) not otherwise None known.
Additional information
20.6% of the mixture consists of component(s) of unknown acute oral toxicity. 87.5% of the mixture consists of component(s) of unknown acute dermal toxicity. 65% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 65% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
